Smart Pharma – Technology brings Unprecedented Opportunities
Increased R&D costs, regulatory hurdles, and the emergence of new diseases are enforcing pharmaceutical companies to rethink their aging business models. The highly regulated pharma is gradually adopting emerging technologies to improve every aspect of the value chain, from drug discovery to patient care. Moreover, the urgency around the COVID-19 pandemic has accelerated the need to embrace digital technologies.
Pharma companies, researchers, innovators, and authorities now aim to unlock the full potential of emerging technologies like AI, big data, IoT, robotics, and 3D printing. The report focuses on how the pharmaceutical sector is leveraging emerging technologies to drive innovation and marching towards massive transformation.
Scope
Theme Exposure Map: presents the top themes impacting the sector over the last three years compared to other sectors.
Patent Filings Chart: displays the top ten themes in the sector with the highest number of patent filings over the last three years.
Innovation Map: key real-world innovation use cases of emerging technologies implemented by enterprises and startups in the sector.
Innovation Insights: innovation examples by each value chain segment of the sector to present key trends.
Vendor Map: represents a sample list of vendors in each use case highlighted in the report.
Key Highlights
Innovations: presents real-world innovation use cases and examples related to the implementation of emerging technologies by companies as well as startups in the pharmaceutical sector. It casts light on how tech-enabled innovations are transforming every segment of the sector value chain.
Reasons to Buy
No surprise that technology has been a driving force in business transformation for years, but the term ‘emerging technologies’ has all of the sudden became the key catalyst to drive the next wave of innovation across sectors.
The sense of urgency weighs different across different sectors, where the direct customer-facing sectors are at the forefront compared to other capital-intensive sectors. Companies in one sector can take cues from successful innovations in other sectors to either draw analogies with existing products, services and processes or transfer strategic approaches for a revolutionary transformation.
Against this backdrop, enterprises need to understand which emerging technologies are impacting their sector and how various companies are implementing them to meet various challenges.
The innovation landscape report in pharma, published by GlobalData as part of an ongoing series, covers some of the key trends, use cases, and real-world examples related to the implementation of emerging technologies across the pharma sector value chain.
Key Players
Table of Contents
Get in touch to find out about our multi-purchase discounts
reportstore@globaldata.com
Tel +44 (0) 20 7947 2960
Every customer’s requirement is unique. We understand that and can customize the report basis your exact research requirements pertaining to market insights, innovation insights, strategy and planning, and competitive intelligence. You can also avail the option of purchasing stand-alone sections of the report or request for a country specific report.
Testimonial
“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.
GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”
“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”
Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.
Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.
Related reports
View more Pharmaceuticals reports